OnCo

Stay in the loop

Leave your email and OnCo will write when something big changes in cancer research. No spam, one click to unsubscribe.

Email updates open shortly. Until then, press Watch on any page to keep it on your list.

drugsTreatmentPhase 2

WJB001

aka Wee1 inhibitor+ Taxol/Abraxane, Wee1 inhibitor+ PARAPLATIN/Aqupla, Wee1 inhibitor+ PARAPLATIN+Taxol, Wee1 inhibitor+ Zejula

WJB001 is a small-molecule inhibitor from Wigen Biomedicine Technology (Shanghai) Co., Ltd., in registered phase 2 trials for metastatic cancer.